Biomerica, Inc. (BMRA) financial statements (2020 and earlier)
Company profile
| Business Address |
17571 VON KARMAN AVENUE IRVINE, CA 92614 |
| State of Incorp. | DE |
| Fiscal Year End | May 31 |
| SIC | 3843 - Dental Equipment and Supplies (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 11/30/2019 Q2 | 8/31/2019 Q1 | 5/31/2019 Q4 | 2/28/2019 Q3 | 11/30/2018 Q2 | 8/31/2018 Q1 | 5/31/2018 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 851 | 808 | 687 | 918 | 1,125 | 584 | 1,205 | ||
| Cash and cash equivalents | 851 | 808 | 687 | 918 | 1,125 | 584 | 1,205 | ||
| Receivables | 1,283 | 859 | 1,455 | 1,077 | 1,261 | 1,014 | 800 | ||
| Inventory, net of allowances, customer advances and progress billings | 2,191 | 2,206 | 2,151 | 2,080 | 2,115 | 2,208 | 2,179 | ||
| Inventory | 2,191 | 2,206 | 2,151 | 2,080 | 2,115 | 2,208 | 2,179 | ||
| Other undisclosed current assets | 186 | 242 | 202 | 254 | 187 | 311 | 300 | ||
| Total current assets: | 4,511 | 4,114 | 4,495 | 4,329 | 4,688 | 4,117 | 4,484 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 1,824 | 1,879 | ✕ | ✕ | ✕ | ||||
| Property, plant and equipment | 304 | 324 | 351 | 346 | 349 | 362 | 351 | ||
| Intangible assets, net (including goodwill) | 110 | 114 | 107 | 95 | 98 | 105 | 99 | ||
| Intangible assets, net (excluding goodwill) | 110 | 114 | 107 | 95 | 98 | 105 | 99 | ||
| Other noncurrent assets | 125 | 129 | 127 | 122 | 120 | 117 | 113 | ||
| Deferred tax assets, net | ✕ | ✕ | ✕ | ✕ | 10 | ||||
| Other undisclosed noncurrent assets | 165 | 165 | 165 | 175 | 175 | 175 | 165 | ||
| Total noncurrent assets: | 2,528 | 2,610 | 750 | 739 | 741 | 759 | 739 | ||
| TOTAL ASSETS: | 7,039 | 6,724 | 5,245 | 5,068 | 5,429 | 4,876 | 5,223 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 1,345 | 944 | 1,038 | 890 | 800 | 583 | 687 | ||
| Accounts payable | 1,345 | 944 | |||||||
| Employee-related liabilities | 227 | 224 | 216 | 215 | 210 | ||||
| Other undisclosed accounts payable and accrued liabilities | 811 | 666 | 584 | 368 | 477 | ||||
| Debt | 200 | 195 | |||||||
| Other undisclosed current liabilities | 439 | 230 | 227 | 224 | 216 | 215 | 210 | ||
| Total current liabilities: | 1,984 | 1,369 | 1,264 | 1,113 | 1,017 | 798 | 897 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1,678 | 1,731 | |||||||
| Operating lease, liability | 1,678 | 1,731 | ✕ | ✕ | ✕ | ||||
| Total noncurrent liabilities: | 1,678 | 1,731 | |||||||
| Total liabilities: | 3,663 | 3,100 | 1,264 | 1,113 | 1,017 | 798 | 897 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 3,376 | 3,624 | 3,981 | 3,954 | 4,412 | 4,078 | 4,326 | ||
| Common stock | 788 | 782 | 774 | 747 | 743 | 716 | 711 | ||
| Common stock, share subscribed but unissued, subscriptions receivable | (16) | (6) | |||||||
| Additional paid in capital | 23,223 | 22,975 | 22,830 | 22,049 | 21,823 | 21,035 | 20,844 | ||
| Accumulated other comprehensive loss | (42) | (40) | (37) | (34) | (32) | (27) | (26) | ||
| Accumulated deficit | (20,578) | (20,093) | (19,587) | (18,801) | (18,123) | (17,645) | (17,194) | ||
| Stockholders' equity note, subscriptions receivable | (9) | ||||||||
| Total stockholders' equity: | 3,376 | 3,624 | 3,981 | 3,954 | 4,412 | 4,078 | 4,326 | ||
| TOTAL LIABILITIES AND EQUITY: | 7,039 | 6,724 | 5,245 | 5,068 | 5,429 | 4,876 | 5,223 | ||
Income statement (P&L) ($ in thousands)
| 11/30/2019 Q2 | 8/31/2019 Q1 | 5/31/2019 Q4 | 2/28/2019 Q3 | 11/30/2018 Q2 | 8/31/2018 Q1 | 5/31/2018 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 1,596 | 1,194 | 1,166 | 1,261 | 1,501 | 1,273 | 1,130 | |
| Cost of revenue | (1,128) | (827) | (985) | (895) | (1,093) | (936) | (862) | |
| Gross profit: | 469 | 367 | 181 | 366 | 408 | 337 | 268 | |
| Operating expenses | (959) | (877) | (946) | (1,073) | (894) | (792) | (912) | |
| Operating loss: | (490) | (510) | (765) | (707) | (486) | (455) | (644) | |
| Nonoperating income | 4 | 4 | 4 | 29 | 9 | 3 | 8 | |
| Investment income, nonoperating | 4 | 4 | 4 | 29 | 9 | 3 | 8 | |
| Interest and debt expense | (0) | (0) | ||||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 0 | |||||||
| Loss from continuing operations before income taxes: | (485) | (505) | (761) | (679) | (477) | (452) | (636) | |
| Income tax expense | (1) | |||||||
| Other undisclosed loss from continuing operations | (24) | (32) | ||||||
| Net loss: | (485) | (506) | (785) | (679) | (477) | (452) | (668) | |
| Other undisclosed net income attributable to parent | 0 | |||||||
| Net loss available to common stockholders, diluted: | (485) | (506) | (785) | (679) | (477) | (452) | (668) | |
Comprehensive Income ($ in thousands)
| 11/30/2019 Q2 | 8/31/2019 Q1 | 5/31/2019 Q4 | 2/28/2019 Q3 | 11/30/2018 Q2 | 8/31/2018 Q1 | 5/31/2018 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (485) | (506) | (785) | (679) | (477) | (452) | (668) | |
| Comprehensive loss: | (485) | (506) | (785) | (679) | (477) | (452) | (668) | |
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (2) | (3) | (3) | (2) | (4) | (1) | (4) | |
| Comprehensive loss, net of tax, attributable to parent: | (487) | (510) | (788) | (680) | (482) | (453) | (672) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.